课题基金 / 基金详情

ASSEMBLY OF THE DIVISION SEPTUM IN ESCHERICHIA COLI

ASSEMBLY OF THE DIVISION SEPTUM IN ESCHERICHIA COLI
大肠杆菌中隔膜的组装
批准号:
6526168
负责人:
DAVID S WEISS
金额:
$19.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2004-07-31

项目摘要

项目成果

DAVID S WEISS的其他基金

相似基金

相关文献

中文摘要
翻译
我们工作的长期重点是细菌的细胞分裂。我们特别感兴趣的是分裂间隔是如何形成的,以及它的形成是如何与细胞周期中的其他事件如染色体分离协调的。一个辅助目标是了解蛋白质如何定位到特定的亚细胞位点。这种兴趣源于对许多参与隔膜组装的蛋白质定位于分裂位点的观察。细胞分裂和蛋白质定位是对包括人类在内的所有生物至关重要的基本细胞过程,也是癌症等疾病的基础,但由于技术限制,通常难以研究。丰富的遗传工具使大肠杆菌成为研究基本细胞过程的理想模式生物。大肠杆菌的隔膜组装至少需要9种必需蛋白质,它们都位于分裂位点。我们的假设是,这些蛋白质形成的复合体包含隔膜组装所需的所有活性,这些蛋白质之间的相互作用对于它们聚集到分裂位点和调节它们的活性是重要的。因此,我们想要更多地了解这些蛋白质的详细功能,确定这些蛋白质之间的相互作用,并了解该集合是否完整。为了解决这些问题,我们将描述FtsI,一种具有与肽聚糖合成相关的酶活性(转肽酶)的膜蛋白。具体来说,我们将(i)使用遗传学和荧光显微镜相结合的方法来鉴定FtsI中将该蛋白靶向到分裂位点的序列;(ii)使用生化和遗传方法寻找与FtsI直接相互作用的蛋白质;(iii)使用荧光显微镜确定三种转糖基酶的亚细胞位置,这些酶被认为参与了间隔肽聚糖的合成并与FtsI相互作用。更好地了解简单细菌系统中的细胞分裂,可能会对包括人类在内的其他生物的这些过程有所启发。此外,更好地了解这些过程可能会导致更多基于知识的方法来开发新的抗生素。在这方面,值得注意的是,这里要研究的四种蛋白质(FtsI和三种转糖基化酶)是β -内酰胺类抗生素的主要靶点。
英文摘要
The long-term focus of our work is cell division in bacteria. In particular, we are interested in how the division septum is formed, and how its formation is coordinated with other events in the cell- cycle such as chromosome segregation. An ancillary objective is to understand how proteins are localized to specific subcellular sites. This interest stems from the observation that many proteins involved in septum assembly are localized to the division site. Cell division and protein localization are fundamental cellular processes of importance to all organisms, including humans, and underlie diseases such as cancer, but are often difficult to study due to technical limitations. The wealth of genetic tools available in Escherichia coli makes this an ideal model organism for studies of basic cellular processes. Septum assembly in E. coli requires at least nine essential proteins, all of which localize to the division site. Our hypothesis is that these proteins form of complex that contains all of the activities need for septum assembly, and that interactions among these proteins are important for their recruitment to the division site and for regulating their activities. Thus, we want to know more about the detailed function of these proteins, to identify interactions among these proteins, and to know whether the set is complete. To approach these issues we will characterize FtsI, a membrane protein with an enzymatic activity (transpeptidase) related to peptidoglycan synthesis. Specifically, we will (i) use a combination of genetics and fluorescence microscopy to identify sequences in FtsI that target this protein to the division site; (ii) use biochemical and genetic approaches to look for proteins that interact directly with FtsI; and (iii) use fluorescence microscopy to determine the subcellular location of three transglycosylases postulated to be involved in synthesis of septal peptidoglycan and to interact with FtsI. A better understanding of cell division in a simple bacterial system might shed light on these processes in other organisms, including humans. In addition, a better understanding of these processes might lead to more knowledge-based approaches to developing new antibiotics. In this regard, it is worth noting that four of the proteins to be studied here (FtsI and the three transglycosylases) are primary targets of beta-lactam antibiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heteroresistance Interdisciplinary Research Unit (Project 2)
  • 批准号:
    10366038
  • 项目类别:
  • 资助金额:
    $35.85万
  • 财政年份:
    2021
  • 负责人:
    DAVID S WEISS
  • 依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
  • 批准号:
    10369416
  • 项目类别:
  • 资助金额:
    $20.86万
  • 财政年份:
    2021
  • 负责人:
    DAVID S WEISS
  • 依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
  • 批准号:
    10518406
  • 项目类别:
  • 资助金额:
    $17.38万
  • 财政年份:
    2021
  • 负责人:
    DAVID S WEISS
  • 依托单位:
Heteroresistance Interdisciplinary Research Unit (Project 2)
  • 批准号:
    10583505
  • 项目类别:
  • 资助金额:
    $55.09万
  • 财政年份:
    2021
  • 负责人:
    DAVID S WEISS
  • 依托单位:
海外基金